this was done by sequential addition to the hsv-infected cells of ( a ) human anti-hsv , ( b ) rabbit antihuman globulin , ( c ) guinea pig antirabbit globulin ( the bridging reagent ) and ( d ) rabbit pap .
C0086418
human
C0027021
pap